Biolatam® 2016

Biolatam® is the biotechnology conference which provides unique access to Latin America, one of the fastest growing life science markets, in a forum for collaboration, discussion and partnering among key industry executives in Latin America, the US and Europe.

International drug developers are increasingly targeting Latin America's emerging market and innovative capabilities in generic pharmaceuticals, clinical trials and drug manufacturing. As well, governmental support for biotechnology companies has increased dramatically over the last decade, lending to a ripe environment for life science partnering.

Biolatam aims at promoting mutual benefits between global companies and US, Latin American and European entities, to facilitate life science investments and technological collaborations. Supported by partneringONE^®, the world's leading partnering system for the life science industry, and combining a unique format of company presentations, discussion panels and one-to-one meetings, Biolatam makes networking an efficient and simple process, maximizing the time of attendees and providing them the most value for two days spent out of the office.

Over 500 international executives from pharmaceutical companies, biotech companies such as health, biofuels, cosmetics, agrifood, and mining; emerging medical technology companies; established large medtech companies; venture capital, private equity, institutional firms and business angels; distributors and hospitals; and service related companies are expected to attend.

For more information and online registration please visit our conference website at https://ebdgroup.knect365.com/biolatam.

Contact:

Camille Del Carmen
EBD Group
Carlsbad, CA
+1 760 930 0500
cdelcarmen@ebdgroup.com

Catharine Moreno Finan
EBD Group GmbH
Munich Germany
T: +49 89 2388 756-25
cmoreno@ebdgroup.com